ニュース

The iShares U.S. Aerospace & Defense ETF rallied 23% to $250, then fell 16% to $210. It is now stabilizing around $217.

GE Aerospace (NYSE:GE) was among Jim Cramer’s stock calls on Mad Money recently as he recapped mega-cap tech earnings. A caller sought Cramer’s opinion of the stock, and in response, he said: I think you should buy it right here. Enough is enough. It’s been going down because people are worried about air travel. I […]

The stock is up over 126% in the last year, as its end markets continue to support long-term growth for the company.

U.S. procurement rules will prohibit Chinese origin rare earth materials in defense applications from January 2027. China currently supplies a large share of global rare earth alloys used in aerospace engines and components. Domestic U.S. rare earth projects are scaling up to supply companies such as GE Aerospace, part of General Electric (NYSE:GE). General Electric (NYSE:GE), trading at $283.57, sits at the center of this supply chain reset through its GE Aerospace business, which depends...

GE HealthCare (NASDAQ: GEHC) currently trades at $59.49, well below the Wall Street consensus price target of $89.74. That implies upside of roughly 50.8% if the analysts are right. GE HealthCare is the medical imaging and diagnostics business spun from General Electric, with about $20.6 billion in annual revenue across Advanced Imaging Solutions, Patient Care ... GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip

Former General Electric investors are extremely happy with two of the companies that emerged from the breakup.

The Strait of Hormuz crisis is spooking markets, but another crisis has been emerging—one that could hit the entire U.S. defense supply chain.

The company reported first-quarter earnings per share of 99 cents. Wall Street was looking for $1.05.

Airbus reported a first-quarter operating profit of €300 million. Wall Street was looking for about €345 million.

GE HealthCare Technologies (NASDAQ:GEHC) reported first-quarter 2026 results that management said landed at the high end of expectations on revenue, while profits and cash flow guidance for the full year were reduced to reflect higher input costs and a first-quarter supplier-related recall in Pharma

ETFs like ITA gain spotlight as global military spending hits $2.89T, rising 2.9%, with Europe leading growth.